Qing-Lei Zeng: Clinical Trials

2 trials sponsored by Qing-Lei Zeng, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 2

Follow Qing-Lei Zeng: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B
Entecavir, Entecavir + Pegylated interferon α-2b - Hepatitis B Virus Infection, Children
Phase 4Not yet recruitingQing-Lei Zeng802026-01-112026-01-16
Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B
Entecavir, Entecavir + Pegylated interferon α-2b - Hepatitis B Virus Infection, Children
Phase 4Not yet recruitingQing-Lei Zeng602026-01-112026-01-16

Conditions studied

Bronchiolitis Obliterans Syndrome (2)  ·  Hepatitis B (2)  ·  Hepatitis B, Chronic (2)

Interventions

entecavir (2)